190 related articles for article (PubMed ID: 12434952)
21. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Pediatr Crit Care Med; 2019 Jul; 20(7):e342-e351. PubMed ID: 31107379
[TBL] [Abstract][Full Text] [Related]
22. Platelet transfusion goals in oncology patients.
Fasano RM; Josephson CD
Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
[TBL] [Abstract][Full Text] [Related]
23. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
Kander T; Tanaka KA; Norström E; Persson J; Schött U
Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870
[TBL] [Abstract][Full Text] [Related]
24. Determination of the rate of reduction in platelet counts in recipients of hematopoietic stem and progenitor cell transplant: clinical implications for platelet transfusion therapy.
del Rosario ML; Kao KI
Transfusion; 1997; 37(11-12):1163-8. PubMed ID: 9426640
[TBL] [Abstract][Full Text] [Related]
25. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
Stanworth SJ; Estcourt LJ; Llewelyn CA; Murphy MF; Wood EM;
Transfusion; 2014 Oct; 54(10):2385-93. PubMed ID: 24724863
[TBL] [Abstract][Full Text] [Related]
26. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
[TBL] [Abstract][Full Text] [Related]
27. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
Callow CR; Swindell R; Randall W; Chopra R
Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
[TBL] [Abstract][Full Text] [Related]
28. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
29. New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding.
Slichter SJ
Curr Opin Hematol; 2011 Nov; 18(6):427-35. PubMed ID: 21946073
[TBL] [Abstract][Full Text] [Related]
30. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation.
Fernández-Muñoz H; Plaza EM; Rivera-Caravaca JM; Candela MJ; Romera M; De Arriba F; Lozano ML; Vicente V; Heras I; Castilla-Llorente C; Rivera J
Hematology; 2018 Oct; 23(9):712-718. PubMed ID: 29582705
[TBL] [Abstract][Full Text] [Related]
31. Platelet utilization and the transfusion trigger: a prospective analysis.
Greeno E; McCullough J; Weisdorf D
Transfusion; 2007 Feb; 47(2):201-5. PubMed ID: 17302764
[TBL] [Abstract][Full Text] [Related]
32. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis.
Ishida A; Handa M; Wakui M; Okamoto S; Kamakura M; Ikeda Y
Transfusion; 1998 Sep; 38(9):839-47. PubMed ID: 9738624
[TBL] [Abstract][Full Text] [Related]
33. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
34. Platelet Transfusion Practices in Critically Ill Children.
Nellis ME; Karam O; Mauer E; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Crit Care Med; 2018 Aug; 46(8):1309-1317. PubMed ID: 29727368
[TBL] [Abstract][Full Text] [Related]
35. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.
Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A
PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290
[TBL] [Abstract][Full Text] [Related]
36. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
37. Randomized Trial of Platelet-Transfusion Thresholds in Neonates.
Curley A; Stanworth SJ; Willoughby K; Fustolo-Gunnink SF; Venkatesh V; Hudson C; Deary A; Hodge R; Hopkins V; Lopez Santamaria B; Mora A; Llewelyn C; D'Amore A; Khan R; Onland W; Lopriore E; Fijnvandraat K; New H; Clarke P; Watts T;
N Engl J Med; 2019 Jan; 380(3):242-251. PubMed ID: 30387697
[TBL] [Abstract][Full Text] [Related]
38. Compliance with prophylactic platelet transfusion trigger in haematological patients.
Eikenboom JC; van Wordragen R; Brand A
Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
[TBL] [Abstract][Full Text] [Related]
39. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
40. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.
Stanworth SJ; Hudson CL; Estcourt LJ; Johnson RJ; Wood EM;
Haematologica; 2015 Jun; 100(6):740-7. PubMed ID: 25795717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]